104 related articles for article (PubMed ID: 9854217)
21. [Flutamide and pseudoporphyria].
Schmutz JL; Barbaud A; Tréchot P
Ann Dermatol Venereol; 1999 Apr; 126(4):374. PubMed ID: 10421946
[No Abstract] [Full Text] [Related]
22. Interstitial pneumonitis related to leuprorelin acetate and flutamide.
Azuma T; Kurimoto S; Mikami K; Oshi M
J Urol; 1999 Jan; 161(1):221. PubMed ID: 10037405
[No Abstract] [Full Text] [Related]
23. [Flutamide-induced hepatic disorder and serum concentrations of flutamide and its metabolites in patients with prostate cancer].
Nakagawa Y; Koyama M; Matsumoto M
Hinyokika Kiyo; 1999 Dec; 45(12):821-6. PubMed ID: 10659414
[TBL] [Abstract][Full Text] [Related]
24. [Fulminant liver failure with a fatal outcome due to flutamide].
Fernández Peña CM; Morano Amado LE; Montes Santiago J; Fachal C
Med Clin (Barc); 1997 Feb; 108(6):237-8. PubMed ID: 9102495
[No Abstract] [Full Text] [Related]
25. Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.
Whelan P
Eur Urol; 2008 Oct; 54(4):823-4. PubMed ID: 18243509
[No Abstract] [Full Text] [Related]
26. Flutamide-induced liver toxicity including fatal hepatic necrosis.
Crownover RL; Holland J; Chen A; Krieg R; Young BK; Roach M; Fu KK
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):911-5. PubMed ID: 8598370
[TBL] [Abstract][Full Text] [Related]
27. Is photopatch testing useful in the investigation of photosensitivity due to flutamide?
Martín-Lázaro J; Buján JG; Arrondo AP; Lozano JR; Galindo EC; Capdevila EF
Contact Dermatitis; 2004 May; 50(5):325-6. PubMed ID: 15209825
[No Abstract] [Full Text] [Related]
28. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.
Tanvetyanon T; Choudhury AM
J Urol; 2004 Apr; 171(4):1627. PubMed ID: 15017238
[No Abstract] [Full Text] [Related]
29. Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone.
Aragon-Ching JB
J Clin Oncol; 2009 Dec; 27(35):e261; author reply e262. PubMed ID: 19884519
[No Abstract] [Full Text] [Related]
30. More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer.
Barrass BJ; Thurairaja R; Persad RA
BJU Int; 2004 Jun; 93(9):1175-6. PubMed ID: 15180599
[No Abstract] [Full Text] [Related]
31. Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer.
Lloyd A; Penson D; Dewilde S; Kleinman L
Prostate Cancer Prostatic Dis; 2008; 11(2):153-9. PubMed ID: 17637761
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
Miyake H; Hara I; Eto H
BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
[TBL] [Abstract][Full Text] [Related]
33. [Hepatotoxicity from flutamide].
Cantalejo Moreira M; García Espinosa V; Martín Gutiérrez JC; García Puig J
Med Clin (Barc); 1997 Dec; 109(20):819-20. PubMed ID: 9493165
[No Abstract] [Full Text] [Related]
34. The 'flare' phenomenon: should we be concerned?
Thurairaja R; Persad R; Peters J; Bahl A
BJU Int; 2005 Jul; 96(1):4-6. PubMed ID: 15963110
[No Abstract] [Full Text] [Related]
35. [Osteoporosis prophylaxis in men? Adverse effects of total androgen blockade in carcinoma of the prostate].
Hüfner M
Internist (Berl); 1999 Aug; 40(8):883. PubMed ID: 10476490
[No Abstract] [Full Text] [Related]
36. [Acute flutamide-induced hepatitis].
Nicolás D; Pérez-EbrI ML; Sarrión JV; Nos P
Gastroenterol Hepatol; 1999 May; 22(5):262-3. PubMed ID: 10396113
[No Abstract] [Full Text] [Related]
37. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? results from a pilot study.
Crook TJ; Bramble J
BJU Int; 2005 Oct; 96(6):918; author reply 918-9. PubMed ID: 16153235
[No Abstract] [Full Text] [Related]
38. [Flutamide-induced late cutaneous pseudoporphyria].
Mantoux F; Bahadoran P; Perrin C; Bermon C; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 1999 Feb; 126(2):150-2. PubMed ID: 10352831
[TBL] [Abstract][Full Text] [Related]
39. [Acute cholestatic hepatitis secondary to flutamide].
Mena FJ; Goyeneche ML; Velicia R; González JM; Bellido J; Caro-Patón A
Rev Esp Enferm Dig; 1998 May; 90(5):376-7. PubMed ID: 9656761
[No Abstract] [Full Text] [Related]
40. Competing risks for patients with localized prostate cancer.
Seidenfeld J; Samson DJ; Albertsen PC
J Natl Cancer Inst; 2007 Oct; 99(20):1498-9. PubMed ID: 17925533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
